BA
LRCX icon

Bard Associates’s Lam Research LRCX Stock Holding History

Bard Associates’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67K Buy
+20
New +$6.07K ﹤0.01% 236

Other funds holding LRCX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bard Associates's LRCX Position: Q2 2026 in Review

Bard Associates opened a new position in Lam Research (LRCX) in Q2 2026: 20 shares worth $8.67K. The stake represents ﹤0.01% of the portfolio and ranks #236 among its holdings.

3,110 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Bard Associates held 20 shares of Lam Research worth $8.67K as of Q2 2026.
  • Lam Research was a new Bard Associates position in Q2 2026.
  • Lam Research made up ﹤0.01% of Bard Associates's portfolio in Q2 2026, its #236 holding.
  • 3,110 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.